We studied 160 patients undergoing elective Caesarean section under spinal anaesthesia who received a preloading volume of 15 ml kg -1 of 10% pentastarch in 0.9% saline, or Hartmann's solution, in a prospective, randomized, double-blind study. We compared the incidence of spinal-induced hypotension in each group. Hypotension was defined as a decrease in systolic arterial pressure to less than 70% of baseline values or ഛ90 mm Hg, whichever was the greater. The groups were comparable in physical characteristics and there was no serious morbidity. Fetal outcome was similar in both groups. Significantly more patients in the Hartmann's group (nϭ38, 47.5%) developed hypotension than in the pentastarch group (nϭ 10, 12.5%) (PϽ0.0001). Linear regression analysis showed that the only significant variable was type of fluid used. Blood glucose concentrations were not related to the presence of hypotension. We conclude that starches may be suitable for preloading in Caesarean section under spinal anaesthesia and provide an alternative to the aggressive use of vasoconstrictors.
In elective Caesarean section under spinal anaesthesia, hypotension has been reported in as many as 85% of patients. 1 Hypotension may be detrimental to the mother and the resulting placental hypoperfusion to the fetus. Traditionally, careful positioning and volume preloading with crystalloid have been used to prevent this. However, crystalloids have a short intravascular half-life and large volumes are needed, which may in itself pose a risk to the mother and fetus. Theoretically, colloids are a better alternative. We have investigated a relatively new colloid, 10% pentastarch in 0.9% saline, for preloading and compared its ability to prevent hypotension with that of Hartmann's solution.
Methods and results
After obtaining approval from the Local Research and Ethics Committee and informed consent, we studied 160 women (ASA I or II) undergoing elective Caesarean section under spinal anaesthesia. Exclusion criteria were: essential hypertension, pre-eclampsia, fetal compromise, diabetes mellitus, multiple pregnancy, polyhydramnios, renal or liver disease and clotting diatheses. All patients had a haemoglobin concentration Ͼ10 g dl -1 . Oral fluids were allowed for up to 4 h before operation. In the operating © British Journal of Anaesthesia theatre, with the patient in the left lateral position and an arterial pressure cuff on the dependent (left) arm, an average of three automated systolic arterial pressure (AP) recordings (Hewlett Packard Patient Monitor 78352A) were calculated as baseline AP. A 14-gauge cannula was inserted into a vein in the right arm and blood glucose concentration (Bayer 'glucotide' glucometer) was measured. A technician prepared the appropriate test solution of pentastarch (10% Pentaspan in 0.9% saline, Geistlich Pharma) or Hartmann's solution using a randomization code prepared by pharmacy and covered it with a black plastic bag to ensure blinding. This was infused over 10-15 min, after which a 1-litre bag of 0.9% saline was connected (but not infused) to the cannula.
The patient was placed in the sitting position and a 25-gauge Whitacre needle (Becton and Dickinson) was introduced into the subarachnoid space (L2-3 interspace). Heavy 0.5% bupivacaine 2.5-3 ml (without opioid) was injected, the dose being determined by the individual anaesthetist. The patient was returned to the left then right lateral position and finally the wedged supine position for surgery. The AP cuff was also moved to keep it on the †Presented in part at the Obstetric Anaesthetists Association Annual Conference, Harrogate, May 1998. dependent (lower) arm at all times and oxygen 5 litre min -1 was administered via a Hudson face mask. Heart rate, AP and oxygen saturation were recorded every 1 min until the end-point of the study when the umbilical cord was clamped.
Hypotension, defined as a decrease in systolic arterial pressure to less than 70% of baseline AP or ഛ90 mm Hg (whichever was the greater), 2 was treated promptly with bolus doses of ephedrine 3-6 mg. The height of the block to light touch at delivery, uterine incision to cord clamping time (U-D interval), time to delivery (spinal insertion to cord clamping time), Apgar scores (at 1 and 5 min) and umbilical venous pH were recorded. A 50% incidence of hypotension was predicted in the Hartmann's group based on previous studies and our experience. We considered the minimum worthwhile clinical effect was to reduce this by 50%, and calculated that 160 patients (80 per group) would be required to confirm this at the 5% significance level with a power of 90%.
Statistical analysis was performed using the chi-square and Mann-Whitney tests for non-parametric data, and the Student's two-tailed t (or the z test when sample sizes were Ͼ30) for parametric data (Intercooled Stata version 4.0 for Windows 95). Multiple linear regression was used to examine the effect of possible confounders on the incidence of hypotension and amount of ephedrine used. PϽ0.05 was considered significant. Data are reported as mean (SD) or median (range).
There were no differences in mean age (30.7 (16-41) and 30 (17-40) yr), weight (80.8 (13.06) and 79.5 (13.35) kg), preoperative blood glucose concentrations (3.6 (1.7-7.0) and 3.5 (1.6-7.0) mmol litre -1 ) or median gestation (38 (36-40) and 38 (34-43) weeks) between the Hartmann's and pentastarch groups, respectively. The Hartmann's and pentastarch groups were similar in mean time to delivery (21.7 (7.6) and 21 (6.95) min), U-D interval (64.5 (43.2) and 71.4 (44.1) s), preload error (the actual volume of preload solution given when this was compared with the calculated 15 ml kg -1 volume; 6.5 (47.2) and 7.0 (45.7) ml), volume of spinal anaesthetic administered (2.75 (0.17) and 2.72 (0.18) ml) and median upper sensory level of the block (T4 (T6 to T2) and T4 (T7 to T2)), respectively.
Significantly more patients in the Hartmann's group (nϭ 38) developed hypotension compared with the pentastarch group (nϭ10) (PϽ0.0001). The mean dose requirement of ephedrine was also higher in those receiving Hartmann's solution (PϽ0.0001). Eighteen patients in the Hartmann's group and one in the pentastarch group experienced hypotension exceeding 3 min total duration (PϽ0.0001) ( Table 1) .
Umbilical venous (UV) pH readings were similar in both groups, although two babies in the Hartmann's group had a UV pH Ͻ7.2. The mothers of both babies had developed hypotension but each child had an Apgar score of 10 at 5 min. One baby (36 weeks' gestation) in the pentastarch group had Apgar scores of 4 and 5 at 1 and 5 min, but there had been no maternal hypotension. Apgar scores were 
Comment
We have demonstrated a significantly lower incidence of hypotension in patients who were preloaded with pentastarch 15 ml kg -1 compared with those who received an equivalent volume of Hartmann's solution. It could be argued that using 2-3 times the volume of Hartmann's solution would have been a fairer comparison, but this would have taken much longer to infuse. We were also concerned that such large volumes might cause excessive haemodilution in an already compromised woman with 'pregnancy-induced anaemia', resulting in reduced oxygen flux to the placenta; in addition, the maternal lung is known to be susceptible to pulmonary oedema. We used UV pH levels as an indicator of adequate placental blood flow. Lack of a significant difference between the groups, despite the different incidences of hypotension, suggests prompt intervention with vasoconstrictors is effective or that the time to delivery was too short for hypotension to cause a significant effect on the placenta. However, current knowledge of the effect of vasoconstrictors on the feto-utero-placental unit is incomplete and prevention of hypotension must be preferable to its correction. These results merit further consideration of the role of colloids, and pentastarch in particular, for preloading.
Mathru and colleagues compared 5% albumin solution (15 ml kg -1 ) with crystalloid during spinal anaesthesia for Caesarean section. There was no hypotension in the albumin group compared with an incidence of 29% in the crystalloid group. 3 A similar study compared 6% hetastarch with Ringer's solution and Ringer's solution alone. The incidence of hypotension was 45% in the hetastarch group and 85% in the Ringer's group. 1 Vercauteren and colleagues have demonstrated that 6% hetastarch with crystalloid is better than hetastarch alone or crystalloid with gelatin, 4 the incidences of hypotension (SAP Ͻ90 mm Hg) being 10%, 40% and 33.3%, respectively.
Pentastarch is a relatively new colloid, derived from waxy starch and composed mostly of amylopectin. It has an average molecular weight of 250 000 (range 150 000-300 000) Da and is presented as a clear to yellow solution of 10% pentastarch in 0.9% saline (pH 5, osmolarity 320 mosmol litre -1 ). Colloid oncotic pressure is 40 mm Hg (cf. 5% albumin 19 mm Hg, 6% hetastarch 30 mm Hg). It is a volume expander (up to 1.5 times the infused volume) which improves haemodynamic status for 12 h. The structural similarity to body glycogen may explain its low antigenic potential and there is no evidence that it significantly interferes with clotting in trauma or major surgery patients. 5 The molecular profile of colloids and the short time to delivery of the fetus after the preload probably means they do not pass to the fetal circulation in appreciable amounts, unlike crystalloids. 6 It is not known if they are excreted in breast milk.
As a preloading solution, pentastarch may be preferable to hetastarch for several reasons. Its shorter plasma expansion effect (12 h vs 36 h) and i.v. half-lives are more appropriate as volume loading is not necessary for prolonged periods. In addition, it causes greater plasma expansion, which may allow smaller volumes to be infused rapidly to achieve the same effect.
The lack of efficacy of crystalloid infusions to prevent hypotension has prompted some authors to abandon routine 477 preloading. 2 However, we feel that the results of this study suggest that there may still be a place for preloading using colloid. Further investigations using starches are warranted before we abandon the practice of preloading in favour of the aggressive use of vasoconstrictors.
